Mc. Bell et al., Oncostatin M induces leukocyte infiltration and cartilage proteoglycan degradation in vivo in goat joints, ARTH RHEUM, 42(12), 1999, pp. 2543-2551
Objective, To evaluate the effect of intraarticular injections of recombina
nt human oncostatin M (rHuOSM) in the goat joint.
Methods. One milliliter of endotoxin-free normal saline (vehicle) containin
g either 40 ng, 200 ng, or 1,000 ng of rHuOSM was injected into the right r
adiocarpal joints (RCJs) of 12 male angora goats, while the left RCJs were
injected with an equivalent volume of vehicle alone. In subsequent studies,
the right and left RCJs of 8 male angora goats were injected with 200 ng o
f rHuOSM, and 1 hour later, the right RCJs were injected with either 5 mu g
of recombinant murine leukemia inhibitory factor binding protein (rMuLBP)
or 1 mg of recombinant human interleukin-1 receptor antagonist (rHuIL-1Ra)
in 1 mi of vehicle, while the left RCJs received 1 mi of vehicle alone. Goa
t joints were examined for clinical features of inflammation, and synovial
fluid (SF) was aspirated on day 0 (before injection) and at days 2 and 6 po
stinjection,
Results, Injections of rHuOSM stimulated dose-dependent increases in the ca
rpal:metacarpal ratio, SF volume, and SF leukocyte numbers, and stimulated
dose-dependent decreases in the cartilage proteoglycan CPG) content ex vivo
and PG synthesis. No significant changes were observed in the control join
ts that received saline alone, or between RCJs that were injected with 200
ng rHuOSM followed by 5 mu g rMuLBP and RCJs that were injected with 200 ng
of rHuOSM alone, except in respect to synovial fluid keratan sulfate conce
ntrations, where a modest statistically significant reduction was observed
in the joints injected with the combination of rHuOSM and rMuLPB, In contra
st, RCJs injected with 200 ng rHuOSM followed by 1 mg of rHuIL-1Ra had sign
ificantly lower SF volumes (P < 0.0001) and a significantly higher rate of
ex vivo PG synthesis (P < 0.0001).
Conclusion. These results indicate that rHuOSM stimulates inflammation and
modulates cartilage PG metabolism in vivo. Some of the effects of rHuOSM in
vivo appear to be due, in part, to elaboration of IL-1, Even at very high
doses, however, the rHuIL-1Ra did not attenuate OSM-mediated cartilage PG r
esorption. Thus, OSM has the potential to contribute to synovitis in vivo a
nd can stimulate cartilage PG resorption in vivo, independent of IL-1.